BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Cytokinetics, Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-13 4:56 pm Sale |
2021-01-11 | 13G | Cytokinetics, Incorporated CYTK |
BIOTECHNOLOGY VALUE FUND L P | 2,728,035 3.900% |
-4,629,984 (-62.92%) |
Filing |
| 2020-11-16 5:29 pm Purchase |
2020-11-12 | 13G | Cytokinetics, Incorporated CYTK |
BIOTECHNOLOGY VALUE FUND L P | 7,358,019 10.400% |
3,419,739 (+86.83%) |
Filing |